 Treatment with the study drugs will continue for the first 12 months of participation in this study. If subjects do not respond after 3 months of treatment or only partially respond to the treatment, dosage may be increased up to 120 unit injections twice a week for 3 months. If subjects still do not respond at the increased dose, the study drug will be discontinued after another 3 months of treatment. 